Literature DB >> 17510531

Characterization of NKT-cell hybridomas expressing invariant T-cell antigen receptors.

Dashtsoodol Nyambayar1, Kazuya Iwabuchi, Emma Hedlund, Satoko Murakawa, Keiko Shirai, Chikako Iwabuchi, Yujiroh Kon, Yusei Miyazaki, Yoshiki Yanagawa, Kazunori Onoé.   

Abstract

Two natural killer T (NKT)-cell hybridomas were established by fusing sorted NKT cells with BW1100 thymoma cells. The first hybridoma line, 1B6, was CD4(+)8(-), whereas the second one, 2E10, was CD4(low)8(-). Initial characterizations revealed that both cell lines expressed an invariant T cell antigen receptor, which could be readily detected with alpha-galactosylceramide-loaded CD1d : Ig fusion protein (alpha-GalCer/CD1d). Sequence analyses of the alpha and beta chains of the T cell receptor V genes revealed that 1B6 and 2E10 cells expressed V alpha 14J alpha 18/V beta 8.2D beta 2J beta 2.7 and V alpha 14J alpha 18/V beta 8.1D beta 1J beta 1.1, respectively. When these hybridoma cells were stimulated with immobilized anti-CD3 monoclonal antibodies, alpha-GalCer/CD1d, or alpha-GalCer in the presence of antigen-presenting cells, they produced IL-4 and IFN-gamma. The expression levels of CD69, CD154, and CD178 were concomitantly up-regulated on both hybridomas upon stimulation. Because it is difficult to isolate a sufficient number of NKT cells, these hybridomas should provide useful platforms to study a variety of functions of NKT cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510531     DOI: 10.3960/jslrt.47.1

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  7 in total

1.  Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.

Authors:  Nathalie Pamir; Timothy S McMillen; Kimberly A Edgel; Francis Kim; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

2.  Osteopontin regulates development and function of invariant natural killer T cells.

Authors:  Hongyan Diao; Kazuya Iwabuchi; Lanjuan Li; Kazunori Onoe; Luc Van Kaer; Shigeyuki Kon; Yoshinari Saito; Junko Morimoto; David T Denhardt; Susan Rittling; Toshimitsu Uede
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

3.  Natural killer T cells are required for lipopolysaccharide-mediated enhancement of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yasuhiro Andoh; Hisako Ogura; Masashi Satoh; Kentaro Shimano; Hironori Okuno; Satoshi Fujii; Naoki Ishimori; Koji Eshima; Hidekazu Tamauchi; Tatsuro Otani; Yukihito Nakai; Luc Van Kaer; Hiroyuki Tsutsui; Kazunori Onoé; Kazuya Iwabuchi
Journal:  Immunobiology       Date:  2012-07-27       Impact factor: 3.144

4.  DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice.

Authors:  Jens M Werner; Elisabeth Busl; Stefan A Farkas; Hans J Schlitt; Edward K Geissler; Matthias Hornung
Journal:  BMC Immunol       Date:  2011-04-29       Impact factor: 3.615

5.  Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor.

Authors:  Piotr Humeniuk; Sabine Geiselhart; Claire Battin; Tonya Webb; Peter Steinberger; Wolfgang Paster; Karin Hoffmann-Sommergruber
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

6.  Natural Killer T Cell-Targeted Immunotherapy Mediating Long-term Memory Responses and Strong Antitumor Activity.

Authors:  Nyambayar Dashtsoodol; Tomokuni Shigeura; Takuya Tashiro; Minako Aihara; Toshihiro Chikanishi; Hiromi Okada; Keigo Hanada; Hirokazu Sano; Akihiko Kurogi; Masaru Taniguchi
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

7.  Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.

Authors:  Jun-Ichi Kashiwakura; Kodai Saitoh; Takeru Ihara; Yuto Sasaki; Kota Kagohashi; Shiyo Enohara; Yuka Morioka; Hiroshi Watarai; Ryuta Muromoto; Yuichi Kitai; Kazuya Iwabuchi; Kenji Oritani; Tadashi Matsuda
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.